Prev Close | 89.13 |
Open | 89.31 |
Day Low/High | 88.21 / 90.64 |
52 Wk Low/High | 48.26 / 99.25 |
Volume | 183.57K |
Avg Volume | 575.20K |
Prev Close | 89.13 |
Open | 89.31 |
Day Low/High | 88.21 / 90.64 |
52 Wk Low/High | 48.26 / 99.25 |
Volume | 183.57K |
Avg Volume | 575.20K |
Exchange | NASDAQ |
Shares Outstanding | 52.06M |
Market Cap | 4.70B |
EPS | 0.40 |
P/E Ratio | 181.54 |
Div & Yield | N.A. (N.A) |
The president-elect's words rattled the sector, though Amgen appears to be shrugging off his remarks.
These stocks are down some 20% over the last 30 months and look ripe for a rise.
Add to longs on a short-term correction.
Only one fund category (of 20) has beaten the S&P 500 over half a decade.
Don't batten down the hatches yet.
I'm content to head into the weekend with my short-term book mostly on the cash side.
Favorable charts for Celldex, Repligen and Arrowhead Research.